Cyclophosphamide is a chemotherapy drug given as an injectable (usually IV) formulation. It’s a prodrug that’s activated in the liver and is used for various cancers and, in some regimens, certain autoimmune conditions. The exact dose and schedule depend on the disease being treated and the specific chemotherapy regimen.
Key points about cyclophosphamide injection
- What it is: An alkylating agent that damages DNA to kill rapidly dividing cells.
- How it’s given: Most commonly as an intravenous infusion in a hospital or clinic. Some regimens may use oral capsules, but “cyclophosphamide injection” usually refers to the IV form.
- What it’s used for:
- Cancers: various lymphomas (e.g., non-Hodgkin lymphoma, Hodgkin lymphoma), leukemias, multiple myeloma, breast cancer, ovarian cancer, and other solid tumors as part of combination regimens.
- Autoimmune diseases: certain regimens for severe rheumatoid arthritis, systemic lupus erythematosus, vasculitis, etc.
- How dosing is determined: Based on body surface area (mg/m2), cancer type, regimen, kidney/liver function, and prior treatments. Dosing is prescribed and administered by a clinician; you won’t self-administer a chemo dose.
- Important safety considerations:
- Myelosuppression: lowered blood counts that can raise infection and bleeding risk.
- Hemorrhagic cystitis: bleeding from the bladder. Often prevented with aggressive hydration and, in higher-dose regimens, a protective drug called mesna.
- Nausea/vomiting, mucositis (sores in the mouth), hair thinning, and fatigue.
- Infertility and potential pregnancy risks; cyclophosphamide is teratogenic. Pregnancy should be avoided during treatment and for a period after, per your oncologist.
- Secondary cancers and other long‑term risks with some regimens.
- SIADH (rare) and electrolyte disturbances.
- Infusion reactions and, rarely, allergic reactions.
- What to monitor:
- Regular blood counts (to watch for neutropenia, anemia, low platelets).
- Kidney and liver function tests.
- Urinalysis or urine tests for blood or other signs of bladder irritation.
- Monitoring for dehydration or urinary symptoms (especially if on high-dose schedules or mesna prophylaxis).
- Important safety actions:
- Stay well hydrated; report dark urine, blood in urine, reduces urine output, or severe bladder pain.
- Tell your healthcare team about any fever, persistent vomiting, unusual bleeding or bruising, or new shortness of breath.
- Avoid live vaccines during treatment; discuss any vaccines with your oncologist.
- Discuss fertility preservation if relevant and possible.
- If you’re pregnant or breastfeeding, stop the drug and contact your doctor immediately.
- If an IV infusion leaks outside the vein (extravasation), contact your clinician right away.
- Preparation and administration notes (for patients):
- Do not attempt to dose or reconstitute cyclophosphamide yourself; this is given by trained healthcare staff.
- If you’re receiving high-dose cyclophosphamide as part of a transplant protocol, there are specific timing and supportive-care steps (e.g., hydration, mesna) to protect the bladder.
- Bring up any other medicines, supplements, or herbal products you take, as some can interact or affect blood counts.
- Common side effects you might be told to monitor at home: fatigue, nausea, mouth sores, low blood counts (leading to infections or easy bruising), hair thinning, and temporary hair loss.
If you tell me your specific goal (e.g., “I want to understand dosing for a CHOP-like regimen,” or “I’m taking cyclophosphamide for an autoimmune condition and want to know what to expect”), I can tailor the information more precisely—including typical regimens, what your doctor might monitor, and common side effects for that particular use. Also, if you have a prescription or plan, share the exact regimen your clinician recommended, and I can explain that regimen in simpler terms.